Clustering of VCAM-1 on the cell surface, acting through Ezrin, triggers Akt activation and protects cancer cells from proapoptotic cytokines such as the TNF-related apoptosis-inducing ligand (TRAIL) (32, 34). Here, AKT1 is linked to cancer.